Artwork

Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S1 Ep19: Gaining Insight Into Genitourinary Cancers in Charlotte

23:45
 
Share
 

Manage episode 222142832 series 2395115
Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

We visited Charlotte, North Carolina for a State of the Science Summit on Genitourinary Cancers. The meeting covered practice-changing clinical trials in nonmetastatic castration-resistant prostate cancer, treatment options for those with castration-sensitive prostate cancer, and the role of surgery in high-risk prostate cancer. Additionally, immunotherapy in advanced renal cell carcinoma was discussed, along with the optimal sequencing of tyrosine kinase inhibitors, and the need for a traditional RCC treatment approach.

  continue reading

483 episodes

Artwork
iconShare
 
Manage episode 222142832 series 2395115
Content provided by Audioboom and OncLive® On Air. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and OncLive® On Air or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

We visited Charlotte, North Carolina for a State of the Science Summit on Genitourinary Cancers. The meeting covered practice-changing clinical trials in nonmetastatic castration-resistant prostate cancer, treatment options for those with castration-sensitive prostate cancer, and the role of surgery in high-risk prostate cancer. Additionally, immunotherapy in advanced renal cell carcinoma was discussed, along with the optimal sequencing of tyrosine kinase inhibitors, and the need for a traditional RCC treatment approach.

  continue reading

483 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide